Landmark Study Shows Avandia(R) (rosiglitazone Maleate) Is More Effective Than Metformin Or A Sulfonylurea In Long-Term Blood Sugar Control

... Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia(R) (rosiglitazone maleate) reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin (p180 mg/dl (10 mmol/l) to a lower blood sugar level more consistent with current therapeutic approaches, FPG 140 mg/dl (7.8 mmol/l). [click link for full article] ...